Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD (DBCOND0050561)

Identifiers

Synonyms
NAFLD- Non Alcoholic Fatty Liver Disease / NAFLD, Non-alcoholic Fatty Liver Disease / NAFLD - Non-Alcoholic Fatty Liver Disease / NAFLD - Nonalcoholic Fatty Liver Disease / NAFLD (Nonalcoholic Fatty Liver Disease) / NAFLD (Non-Alcoholic Fatty Liver Disease) / NAFLD - Non Alcoholic Fatty Liver Disease / NAFLD( Non-alcoholic Fatty Liver Disease ) / Fatty Liver Disease, Nonalcoholic / Non-alcoholic Fatty Liver Disease NAFLD / Non-alcoholic Fatty Liver Disease (NAFLD / Nonalcoholic Fatty Liver Disease (NAFLD) / Non Alcoholic Fatty Liver Diseases (NAFLD) / Non- Alcoholic Fatty Liver Disease / Non-alcoholic Fatty-liver Disease / Non Alcoholic Fatty Liver Disease / Non Alcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Fatty Liver Disease / Non-Alcoholic Fatty Liver Disease / Non-Alcoholic Fatty Liver Disease (NAFLD) / Non-alcoholic fatty liver disease (disorder) / Non-alcoholic fatty liver / Fatty (change of) liver, not elsewhere classified / Non-alcoholic fatty liver (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05358496
Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)No drug interventionsNot AvailableNot Availableunknown_status
NCT06338618
Manual Therapy in Metabolic Liver DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT05909631
Comparing Effects of Beetroot Juice and Mediterranean Diet on Liver Enzymes and Sonography in Patients With NAFLDNo drug interventionstreatment1completed
NCT00928473
The Danish Childhood Obesity BiobankNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04698486
Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLDNo drug interventionsbasic_scienceNot Availablecompleted
NCT06601361
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University HospitalNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02581085
Tocotrienol Against the Progression of End Stage Liver Diseaseother2recruiting
NCT03583437
Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.No drug interventionshealth_services_researchNot Availablecompleted
NCT04109742
Curcumin for Pediatric Nonalcoholic Fatty Liver Diseasetreatment2withdrawn
NCT06115876
Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) ProgramNo drug interventionsNot AvailableNot Availablerecruiting
NCT04480710
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjectstreatment2completed
NCT05218538
Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.No drug interventionsNot AvailableNot Availableunknown_status
NCT04371042
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03467217
Losartan for the Treatment of Pediatric NAFLDtreatment2terminated
NCT03678727
Effects of Exercise on VLDL-TG MetabolismNo drug interventionsNot AvailableNot Availablecompleted
NCT03646292
Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Non-alcoholic Fatty Liver Disease in Type 2 Diabetic Patients With Fatty Livertreatment4unknown_status
NCT04395950
Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolismbasic_science1withdrawn
NCT01264198
The Role of Resistance Training in Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT00823277
Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for OverweightNo drug interventionsNot AvailableNot Availablecompleted
NCT02690792
Effect of Vitamin E on Non-Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT01277094
A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver DiseaseNo drug interventionstreatment1completed
NCT01307254
Association Between Non-alcoholic Fatty Liver Disease and Iron StatusNo drug interventionsNot AvailableNot Availableunknown_status
NCT01677325
The Clinical Trail Of NAFLD Treated By Traditional Chinese MedicineNo drug interventionstreatment1completed
NCT06588699
Digoxin in NASH (CODIN)treatment2not_yet_recruiting
NCT01679197
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophytreatment2completed
NCT00596934
Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)treatment2completed
NCT06097338
Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFFNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06626074
Exploratory Study of MRI Biomarkers of NASHNo drug interventionsotherNot Availablenot_yet_recruiting
NCT06559878
Hepatic Mitochondrial Metabolism in Fatty Liver Disease in HumansNo drug interventionsbasic_scienceNot Availableenrolling_by_invitation
NCT06338449
The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04946786
Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT04835831
Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT02354976
A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.treatment2completed
NCT06024408
A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk FactorNo drug interventionstreatment1recruiting
NCT02781584
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)treatment2completed
NCT03459079
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Diseasetreatment2completed
NCT01544751
Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus AtorvastatintreatmentNot Availableunknown_status
NCT02217345
Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Diseasetreatment2completed
NCT02213224
Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Diseasetreatment4unknown_status
NCT02196831
Tesamorelin Effects on Liver Fat and Histology in HIVtreatmentNot Availablecompleted
NCT03042767
Anti-LPS Antibody Treatment for Pediatric NAFLDNo drug interventionstreatment2completed
NCT03525769
Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 DiabetesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02044523
Noninvasive Staging of Liver Fibrosis: MR vs UltrasoundNo drug interventionsNot AvailableNot Availablecompleted
NCT03836443
Postprandial Lipotoxicity and Nonalcoholic Fatty Liver DiseaseNo drug interventionsotherNot Availablecompleted
NCT01265498
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)treatment2completed
NCT03486899
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosistreatment2completed
NCT01705522
Multimodal Approach in IBD PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03572465
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic SteatohepatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04059029
Nonalcoholic Fatty Liver Disease in Morbidly Obese PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02244944
Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLDtreatment2terminated
NCT01529268
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Childrentreatment2 / 3completed
NCT03486912
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosistreatment2completed
NCT01930123
Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Diseasesupportive_care2terminated
NCT03451279
A Nonabsorbable Ileal Apical Sodium-Dependent Bile Acid Transporter Inhibitor for Nonalcoholic Steatohepatitistreatment2withdrawn
NCT01324414
Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic SteatohepatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01188083
Effects of Dietary Fructose Reduction in Children With Hepatic SteatosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06623539
Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Diseasetreatment2active_not_recruiting
NCT03300661
Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle MedicineNo drug interventionstreatmentNot Availablecompleted
NCT01277237
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Diseasetreatment3completed
NCT01834300
The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatmentNot Availableunknown_status
NCT01874249
Non Invasive Assessment of Liver Fibrosis in Fatty Liver DiseaseNo drug interventionsdiagnosticNot Availablecompleted
NCT06080386
UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)No drug interventionsNot AvailableNot Availablerecruiting
NCT02178839
The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT03276039
Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C VirusNo drug interventionsNot AvailableNot Availablecompleted
NCT03590626
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseasetreatmentNot Availablecompleted
NCT01482065
The Sleep, Liver Evaluation and Effective Pressure StudyNo drug interventionstreatment2completed
NCT04442620
Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical ActivityNo drug interventionspreventionNot Availableunknown_status
NCT01842282
Amlexanox for Type 2 Diabetes and Obesitytreatment2terminated
NCT03135873
Mastiha Treatment for Obese With NAFLD DiagnosisNo drug interventionstreatmentNot Availablecompleted
NCT02686476
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 DiabetestreatmentNot Availablecompleted
NCT01999101
Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) PatientsNo drug interventionstreatment2completed
NCT01754714
Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control GroupNo drug interventionstreatment3completed
NCT01511523
Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)No drug interventionssupportive_careNot Availableunknown_status
NCT01327443
Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT02038387
Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatmentNot Availableunknown_status
NCT01492283
Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without DiabetesNo drug interventionsNot AvailableNot Availablecompleted
NCT02248311
"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic PopulationNo drug interventionsNot AvailableNot Availableunknown_status
NCT02820285
Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASHNo drug interventionsbasic_scienceNot Availablecompleted
NCT01553500
Glucomannan Effects on Children With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatment2completed
NCT02941549
Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLDtreatment2completed
NCT01556113
Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT03850886
Nicotinamide in Non-Alcoholic Fatty Liver Disease PatientsNo drug interventionstreatment2completed
NCT02134522
The Role of Obstructive Sleep Apnea in Children With Fatty Liver DiseaseNo drug interventionstreatmentNot Availableterminated
NCT01956825
The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty LiverNo drug interventionstreatment4unknown_status
NCT01634048
The Effect of Protein-enriched Diet on Body Composition and AppetiteNo drug interventionstreatmentNot Availablecompleted
NCT05426382
A Digital Solution for Individuals With Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT01966627
Genetics of Fatty Liver Disease in ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT01674972
Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy ControlsNo drug interventionsNot AvailableNot Availablecompleted
NCT01987310
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin TreatmenttreatmentNot Availablewithdrawn
NCT02201160
Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric PatientsNo drug interventionstreatment1 / 2unknown_status
NCT05211284
Saroglitazar Magnesium 4 mg for NAFLD in People Living With HIV in the UStreatment2terminated
NCT06482112
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)treatment2recruiting
NCT00658164
Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron StoresNo drug interventionstreatment3unknown_status
NCT04369521
Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT06564584
Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLDNo drug interventionstreatment2recruiting
NCT00930384
A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With PsoriasisNo drug interventionsNot AvailableNot Availablecompleted
NCT00868933
Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02933554
Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05507151
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic SteatohepatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01934777
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitistreatment3completed
NCT05877547
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)treatment2active_not_recruiting
NCT04282447
Screening of NASH in Oupatients Followed in Various Hospital Specialty Clinics at the University Hospital of StrasbourgNo drug interventionsNot AvailableNot Availableunknown_status
NCT01399645
Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetestreatment2completed
NCT01828528
Impact of Bariatric Surgery on Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03067428
Effects of Fructose Restriction on Liver SteatosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT02148471
Fatty Acids, Genes and Microbiota in Fatty LiverNo drug interventionsNot AvailableNot Availablecompleted
NCT05560607
Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver DiseaseNo drug interventionsother1completed
NCT06441409
Serum Ferritin Levels and Metabolic Dysfunction Associated Steatotic Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04820556
Gut Microbiota in Chronic Noncommunicable DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT01139632
The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT01645852
A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver ResectionNo drug interventionssupportive_careNot Availablecompleted
NCT02717000
NASH: Non-invasive Diagnostic Markers and ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT01355575
Rifaximin in Fatty Liver Diseasetreatment4terminated
NCT02132442
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in DiabetesNo drug interventionstreatment3completed
NCT04801849
Vitamin E Dosing Studytreatment2recruiting
NCT03434613
Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Diseasetreatment4completed
NCT00885313
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)treatment1 / 2completed
NCT04710524
FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisNo drug interventionstreatment2unknown_status
NCT03847116
Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00983463
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)No drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05495139
Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT01354626
Dietary Protein and Hepatic Fat AccumulationNo drug interventionspreventionNot Availablecompleted
NCT05497765
An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT00637520
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control StudyNo drug interventionsNot AvailableNot Availableterminated
NCT00994682
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)treatment4completed
NCT03248882
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)treatment2completed
NCT06368882
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease(OCEAN PROJECT)No drug interventionstreatment4recruiting
NCT03566173
Association Between Nonalcoholic Fatty Liver Disease and Acute PancreatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06138327
A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluriatreatment1withdrawn
NCT03674476
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Functiontreatment1completed
NCT01446276
Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver DiseaseNo drug interventionsbasic_scienceNot Availablecompleted
NCT04766476
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatment1terminated
NCT02684591
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophytreatment2completed
NCT03461562
Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT03375580
Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLDtreatmentNot Availableunknown_status
NCT02132780
Autonomic Dysfunction in Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01006889
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Diseasetreatment4completed
NCT03656744
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)No drug interventionstreatment2completed
NCT05583344
Phase 2b Study of GSK4532990 in Adults With NASHNo drug interventionstreatment2recruiting
NCT02412540
Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASHNo drug interventionstreatmentNot Availablecompleted
NCT00650546
Role of Exenatide in NASH-a Pilot Studyother2 / 3completed
NCT00870012
Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and PrebioticsNot AvailableNot Availablecompleted
NCT01707914
Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver DiseaseNo drug interventionspreventionNot Availablecompleted
NCT05625750
Observational Study About Patients Diagnosed With NAFLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT03786523
Time Restricted Feeding on Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT05330923
Effect of NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04399538
Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitisbasic_science2completed
NCT01244503
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)No drug interventionsdiagnostic2terminated
NCT03386890
Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver FibrosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02513121
Dietary Treatment Study of Pediatric NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT04906421
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)treatment2completed
NCT03366987
Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT06449833
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLDtreatment4recruiting
NCT06166797
Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03774511
Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled TrialNo drug interventionstreatmentNot Availablecompleted
NCT04186793
Comparison of Dietary Sugar Reduction MethodsNo drug interventionstreatmentNot Availablecompleted
NCT05550688
Weight Gain After Smoking Cessation and NAFLDNo drug interventionsNot AvailableNot Availablecompleted
NCT02018237
High Fructose Corn SyrupNo drug interventionsdiagnosticNot Availablecompleted
NCT06257732
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on MyokinesNo drug interventionstreatmentNot Availablerecruiting
NCT04772352
Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gouttreatment2unknown_status
NCT02117700
Fatty Liver Disease in Obese ChildrenNo drug interventionstreatment1 / 2completed
NCT05010070
The University of Michigan Wellness for Liver Health StudyNo drug interventionstreatment1 / 2completed
NCT01735799
THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOSNo drug interventionsNot AvailableNot Availableunknown_status
NCT01045499
LAGB as a Treatment for Morbid Obesity in AdolescentsNo drug interventionstreatmentNot Availablecompleted
NCT01208649
Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)treatment4completed
NCT00699036
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)treatment2unknown_status
NCT01940263
Purified Anthocyanin and Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatment0completed
NCT01084486
Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver DiseaseNot Available1 / 2completed
NCT02029586
Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosistreatment2terminated
NCT04988230
Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD ):a 12-month Follow-up StudyNo drug interventionstreatmentNot Availablecompleted
NCT05523648
Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLDtreatment0completed
NCT02863757
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00633282
Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Diseasetreatment2completed
NCT04321031
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)basic_science2completed
NCT04845373
Effect of Mediterranean Diet in Obese Adolescents With Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT01657773
Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant NeoplasmNo drug interventionsNot AvailableNot Availablecompleted
NCT05697991
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes MellitusNo drug interventionsNot AvailableNot Availablerecruiting
NCT01210989
Trial of Hepaguard® in Adults With Nonalcoholic SteatohepatitisNo drug interventionstreatmentNot Availablecompleted
NCT03683589
De Novo Lipogenesis in Severity of NAFLDNo drug interventionsNot AvailableNot Availablecompleted
NCT04944992
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)treatment2completed
NCT04132440
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06044467
The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjectstreatment1completed
NCT05459701
Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)treatment4recruiting
NCT04988204
Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT02469272
Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Studytreatment1unknown_status
NCT03998514
A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatment1completed
NCT03445208
A Study of Experimental Medication BMS-986036 Given to Healthy Participantstreatment1completed
NCT02422238
Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT04216589
Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)treatment2completed
NCT05970640
A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver DiseaseNo drug interventionstreatment1active_not_recruiting
NCT06465186
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)treatment2recruiting
NCT04857437
Study in Healthy Adults Evaluating PF-07202954No drug interventionsbasic_science1completed
NCT04882644
Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatmentNot Availablecompleted
NCT04999124
Characteristics of NAFLD Among Type 2 Diabetes PatientsNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT05462353
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASHNo drug interventionstreatment2recruiting
NCT05499585
Treating Pediatric NAFLD with NutritionNo drug interventionstreatmentNot Availablecompleted
NCT05724134
Pancreatic Clamp in NAFLDbasic_science1recruiting
NCT05729282
Glycemic Effect of Diazoxide in NAFLDbasic_science1recruiting
NCT06558422
Human Models of Selective Insulin Resistance: Pancreatic Clampbasic_science1not_yet_recruiting
NCT06596382
Tocotrienol As a Treatment for Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT03373643
Obstructive Sleep Apnea and Non-alcoholic Fatty Liver DiseaseNo drug interventionsscreeningNot Availableunknown_status
NCT01680003
Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatment2unknown_status
NCT06113003
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatment1 / 2recruiting
NCT05712603
The Nijmegen-Leiden-Amsterdam 2-tiered Care Path StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03791203
Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT05245890
Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD IndividualsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04342390
Effects of High-Intensity Interval Training Exercise in Adolescents With HepatosteatosisNo drug interventionstreatmentNot Availablecompleted
NCT02498990
Low Calorie Diet and DiabetesNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT02496390
Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLDNo drug interventionstreatment1 / 2completed
NCT04400864
Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT04130321
Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in HumansNo drug interventionspreventionNot Availablecompleted
NCT04907721
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic SteatosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT03915002
Integrated Approaches for Identifying Molecular Targets in Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04666402
Integrated Diagnostics for Early Diagnosis of Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT04117802
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic SyndromeNo drug interventionspreventionNot Availablecompleted
NCT05464784
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaNo drug interventionstreatment2recruiting
NCT04098484
Biological Adaptations of Strength Training.No drug interventionstreatmentNot Availablecompleted
NCT06095479
Ultrasound Liver Fat Quantification on Pediatric PatientsNo drug interventionsbasic_scienceNot Availablerecruiting
NCT05956379
Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.No drug interventionstreatmentNot Availableenrolling_by_invitation
NCT02702479
Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic RiskNo drug interventionsNot AvailableNot Availableunknown_status
NCT02568787
The Effect of an RBAC Supplement (BRM4) on NAFLDNo drug interventionsbasic_scienceNot Availablecompleted
NCT00230087
Iron Depletion Therapy for Type 2 DM and NAFLDNo drug interventionstreatment2completed
NCT01696487
Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.No drug interventionspreventionNot Availablecompleted
NCT03444233
Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women.No drug interventionsprevention4completed
NCT04988633
"CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.No drug interventionstreatmentNot Availablecompleted
NCT00575133
Prospective Cohort Study in Patients With NAFLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT06126354
Dexamethasone/Pancreatic Clamp P&Fbasic_science1withdrawn
NCT04594954
Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT01373554
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Diseasetreatment2completed
NCT06007651
A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)No drug interventionsbasic_science1recruiting
NCT04302051
Assessment of Fatty Liver With Thermo-acoustic DeviceNo drug interventionsNot AvailableNot Availablerecruiting
NCT06140953
Benefits of Trimetazidine in MAFLD Pateintstreatment2recruiting
NCT02263677
Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRItreatment4withdrawn
NCT00870077
A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT06053177
Multi-morbidity Screening in People With Type 2 Diabetes and Pre DiabetesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03801577
Hepaxa Management of Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT02500147
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)treatment4active_not_recruiting
NCT04850547
Effect of Fatty Liver Disease on Bone DensityNo drug interventionsNot AvailableNot Availableunknown_status
NCT03354247
Lifestyle Intervention in Fatty Liver (NAFLD)No drug interventionstreatmentNot Availableunknown_status
NCT05217745
MLCT Oil for Fatty Liver - PASS TrialNo drug interventionstreatmentNot Availableunknown_status
NCT03369145
High-fat Overfeeding, Hepatokines and Appetite RegulationNo drug interventionsbasic_scienceNot Availablecompleted
NCT01963845
Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Diseasetreatment2completed
NCT03339245
Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot StudyNo drug interventionsbasic_scienceNot Availablecompleted
NCT02006498
Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)treatment2completed
NCT05325398
Effect of Molecular Hydrogen in Patients With NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT04198805
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)treatment2completed
NCT02285205
A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLDtreatment4completed
NCT02491905
Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease PatientsNo drug interventionstreatment2completed
NCT02568605
Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT02528305
The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/SteatohepatitisNo drug interventionstreatmentNot Availablecompleted
NCT05560997
Metabolic Subtypes of Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03864783
The Effect of Curcumin on Liver Fat Content in Obese SubjectsNo drug interventionstreatmentNot Availablecompleted
NCT02077283
Urinary Metabonomics of Two Major Patterns of NAFLDNo drug interventionsNot AvailableNot Availableunknown_status
NCT03819283
NASH and Coronary DiseaseNo drug interventionsdiagnosticNot Availableunknown_status
NCT03910361
Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseasestreatment4completed
NCT02930161
Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrometreatment2terminated
NCT06348628
Motivational Interviewing in the Management of Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03674528
Technical Validation of MR Biomarkers of Obesity-Associated NAFLDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06392828
EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT01958411
Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)No drug interventionsNot AvailableNot Availablecompleted
NCT01712711
Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatment2completed
NCT02176811
Plasma Betatrophin Levels in Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00887393
Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery CandidatesNo drug interventionstreatmentNot Availablecompleted
NCT06144593
The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 DiabetesNo drug interventionsotherNot Availablerecruiting
NCT05894993
Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06026293
Pharmacoeconomic Evaluation of the Cost/Effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03183193
Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)No drug interventionstreatmentNot Availableunknown_status
NCT01875978
Effect of Phytosterols on Nonalcoholic Fatty Liver DiseaseNo drug interventionspreventionNot Availablecompleted
NCT03513588
2-Week Study In People With Nonalcoholic Fatty Liver DiseaseNo drug interventionsbasic_science1completed
NCT04688307
Cigarette Smoking in Non-alcoholic SteatohepatitisNo drug interventionstreatmentNot Availablecompleted
NCT04647409
Screening for NAFLD in FlandersNo drug interventionsscreeningNot Availablerecruiting
NCT01985009
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.No drug interventionsdiagnosticNot Availablecompleted
NCT03995056
Exercise Study in Subjects With NAFLDNo drug interventionsbasic_scienceNot Availablecompleted
NCT05200156
Impact Of Choline in Patients With NAFLDNo drug interventionssupportive_careNot Availablerecruiting
NCT06011356
Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01257685
Selenoprotein P and Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02383485
Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in ChildrenNo drug interventionspreventionNot Availablecompleted
NCT05200585
Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver DiseaseNo drug interventionspreventionNot Availablecompleted
NCT04043585
Bariatric Surgery on NASHNo drug interventionsNot AvailableNot Availablecompleted
NCT05006885
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)treatment1completed
NCT01619215
The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT04841915
A Randomized Controlled Trial of Effects of DAIry PROtein Products on Liver Disease Severity and Metabolism in Patients With Non-Alcoholic Fatty Liver Disease.No drug interventionstreatmentNot Availableunknown_status
NCT04785937
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD PatientsNo drug interventionsdiagnosticNot Availableunknown_status
NCT03836937
Role of Obeticholic Acid in the Patients of NAFLD With Raised ALTtreatmentNot Availablecompleted
NCT02390232
Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASHNo drug interventionsNot AvailableNot Availablecompleted
NCT05827432
FCI Effectiveness in NAFLD StratificationNo drug interventionsbasic_scienceNot Availablesuspended
NCT01791452
Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04336800
Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry)No drug interventionsNot AvailableNot Availablecompleted
NCT05209100
Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04384159
Combination Diagnostic Strategies in NAFLDNo drug interventionsNot AvailableNot Availablecompleted
NCT03796975
Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Diseasetreatment4completed
NCT05259475
Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study)No drug interventionsotherNot Availablecompleted
NCT02716870
Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk FactorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05416970
The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease EvolutionNo drug interventionsNot AvailableNot Availablecompleted
NCT03749070
Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER TrialNo drug interventionstreatmentNot Availableunknown_status
NCT05268042
Moderately Carbohydrate-restricted Diet to Treat NAFLD in AdolescentsNo drug interventionstreatmentNot Availablerecruiting
NCT04501042
Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT04042142
Glucagon Resistance in Patients With NAFLDNo drug interventionsbasic_scienceNot Availablecompleted
NCT00941642
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Diseasetreatment4unknown_status
NCT02400099
Protein-rich Diet and NAFLD in Bariatric SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT05802199
Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03245606
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04575506
Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty LiverNo drug interventionstreatmentNot Availableunknown_status
NCT05897606
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLDNo drug interventionstreatment1completed
NCT05810506
Non-Alcoholic Fatty Liver Disease and Anthropometric MeasurementsNo drug interventionsNot AvailableNot Availablecompleted
NCT02330549
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLDtreatment2completed
NCT01654549
Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic SteatohepatitisNo drug interventionstreatment2completed
NCT05106049
Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.No drug interventionsNot AvailableNot Availableunknown_status
NCT05402449
To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota ModulationNo drug interventionssupportive_careNot Availablecompleted
NCT04142749
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosistreatment3completed
NCT05813249
Semaglutide in Nonalcoholic Fatty Liver Diseasetreatment4completed
NCT03811236
Cold-induced Brown Fat Activation and Hepatic SteatosisNo drug interventionsbasic_scienceNot Availablerecruiting
NCT03128918
Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02285218
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLDNo drug interventionsNot AvailableNot Availableunknown_status
NCT04336618
Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT04951219
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)treatment3recruiting
NCT05742919
A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenNo drug interventionstreatment1completed
NCT03627819
Plant Sterols and Plant Stanols and Liver InflammationNo drug interventionstreatmentNot Availableunknown_status
NCT03635541
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT02696941
SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitisbasic_science1completed
NCT03439917
Effects of Carnitine Supplementation on Liver and MuscleNo drug interventionsbasic_scienceNot Availablecompleted
NCT04783116
Plant Stanols and Liver Inflammation in Overweight and Obese ChildrenNo drug interventionstreatmentNot Availableunknown_status
NCT06206616
Liver Steatosis in Pediatric CD PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04422496
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy SubjectsNo drug interventionstreatment1completed
NCT00816296
Evaluation of Intestinal Microbiome in Obese KidsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05579158
Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled TrialNo drug interventionstreatmentNot Availablecompleted
NCT06101758
Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER StudyNo drug interventionsdiagnosticNot Availablerecruiting
NCT01975935
Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patientstreatment2completed
NCT05942963
Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLDtreatment4not_yet_recruiting
NCT04671186
Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With FibroscanNo drug interventionstreatmentNot Availablecompleted
NCT03648086
Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT06240039
Direct Versus Indirect Effect of Amino Acids on HepatokinesNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT02644239
Impact of Ketogenic Diet on Lipoproteins in Refractory EpilepsyNo drug interventionstreatmentNot Availableunknown_status
NCT02298439
Fatty Liver Patient RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05946148
Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)Not AvailableNot Availablecompleted
NCT03608748
Early Detection of Advanced Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04574557
Micro RNA Levels in NAFLDNo drug interventionsNot AvailableNot Availableunknown_status
NCT05120557
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHNo drug interventionsdiagnosticNot Availableunknown_status
NCT05741957
Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT01262326
Determination of the Effect of Extreme Dietary Carbohydrate Restriction on Hepatic Glucose ProductionNo drug interventionsbasic_scienceNot Availablecompleted
NCT03256526
6-week Safety and PD Study in Adults With NAFLDbasic_science2completed
NCT06501326
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Diseasetreatment4recruiting
NCT02258126
Effect of Exercise on Hepatic Fat in Overweight ChildrenNo drug interventionstreatmentNot Availablecompleted
NCT01856465
Intestinal Microbiota and NAFLD Pre and Post Bariatric SurgeryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05890365
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight IndividualsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03511365
Effects of Probiotic on Inflammation and Microbiota in Patients With NASHbasic_science1 / 2terminated
NCT00816465
Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatment1completed
NCT05526274
Clinical Epidemiology of NAFLD in Children and AdolescentsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02974374
Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjectstreatment1completed
NCT02077374
A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminasestreatment2completed
NCT05686174
Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLDNo drug interventionstreatment1not_yet_recruiting
NCT06015620
Comorbidities Resolution After MGB Surgery and Change in Body CompositionNo drug interventionsNot AvailableNot Availablerecruiting
NCT01104220
Role of Immune System in Obesity-related Inflammation and Cardiometabolic RiskNo drug interventionsotherNot Availableactive_not_recruiting
NCT05751720
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 AnalogueNo drug interventionstreatment1 / 2recruiting
NCT03985020
Super HEROES: Searching How the Extract Rebaudioside Occludes Excess SteatosisNo drug interventionstreatmentNot Availablecompleted
NCT04227782
MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04104282
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.No drug interventionsNot AvailableNot Availableunknown_status
NCT03467282
Probiotics in NASH Patients - PROBILIVER TRIALNo drug interventionstreatmentNot Availableunknown_status
NCT03839082
Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT03970031
A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASHNo drug interventionstreatment3unknown_status
NCT05301231
Omics-based Predictors of NAFLD/Potential NASHNo drug interventionsNot AvailableNot Availableunknown_status
NCT03972631
Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese AdultsNo drug interventionstreatmentNot Availableunknown_status
NCT02682173
Magnetic Resonance Imaging (MRI) Fat Quantification of the LiverNo drug interventionsbasic_scienceNot Availablecompleted
NCT00730873
Fatty Liver and Obstructive Sleep ApneaNo drug interventionstreatmentNot Availablecompleted
NCT02637973
Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetestreatment4completed
NCT05885373
A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLDNo drug interventionsotherNot Availablecompleted
NCT04475276
Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver DiseasesNo drug interventionstreatment4recruiting
NCT04048876
Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosistreatment2terminated
NCT05474560
Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patientstreatment4completed
NCT02337660
Involvement of Steatosis-induced Glucagon Resistance in HyperglucagonaemiaNo drug interventionsbasic_scienceNot Availablecompleted
NCT04871360
Effect of L-Citrulline Supplementation on NAFLD in Adolescents With ObesityNo drug interventionstreatmentNot Availablecompleted
NCT04800094
Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT06152991
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for EfficacyNo drug interventionstreatment3enrolling_by_invitation
NCT01363791
Meta-analyses of Fructose and Cardiometabolic RiskNo drug interventionsNot AvailableNot Availableunknown_status
NCT01579162
Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal CirculationNo drug interventionsdiagnosticNot Availablecompleted
NCT04989062
Predicting Obesity Consequences Using Body Measure and Urine MetabolomicsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04101162
NAFLD Study: US vs Liver BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT03357380
A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Livertreatment1completed
NCT05486429
Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by UltrasoundNo drug interventionsNot AvailableNot Availableunknown_status
NCT04074889
The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty LiverNo drug interventionstreatmentNot Availableunknown_status
NCT05613192
Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patientstreatment3recruiting
NCT02116192
Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in AdolescentsNo drug interventionspreventionNot Availablecompleted
NCT01083992
Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)treatmentNot Availableunknown_status
NCT04141592
Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05866744
Effects of Time-restricted Hypocaloric Diet in Patients With NAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT04969744
Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD)No drug interventionsotherNot Availablerecruiting
NCT05779644
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitustreatmentNot Availablerecruiting
NCT04440540
Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based StudyNo drug interventionssupportive_careNot Availableterminated
NCT03142867
The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in AdultsNo drug interventionsNot AvailableNot Availableterminated
NCT06512701
Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06133101
Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatment2recruiting
NCT04690972
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03912272
12-Month Once-a-week HIIT Improves Body Adiposity and Liver FatNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02642172
Prebiotics in Patients With Non-alcoholic Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT03743272
Repeatability and Reproducibility of Multiparametric MRINo drug interventionsNot AvailableNot Availableunknown_status
NCT02947568
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05063968
A Clinical Trial of XZP-6019 Tablets in Healthy SubjectsNo drug interventionstreatment1unknown_status
NCT03487068
Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver DiseaseNo drug interventionsdiagnosticNot Availableunknown_status
NCT06211868
Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04059068
Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease.No drug interventionsNot AvailableNot Availablecompleted
NCT02787668
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With ObesityNo drug interventionstreatmentNot Availablecompleted
NCT05870969
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)No drug interventionsNot AvailableNot Availablerecruiting
NCT02951546
Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics BaseNo drug interventionsbasic_scienceNot Availablecompleted
NCT00694746
Study of Fish Oil to Reduce ALT Levels in Adolescentstreatment1terminated
NCT06005012
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMtreatment2recruiting
NCT02461212
Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in YouthNo drug interventionsdiagnosticNot Availablecompleted
NCT04355910
Intermittent Fasting in Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT01547910
Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in ChildrenNo drug interventionstreatment2completed
NCT06024681
Impact of FMT on the Phenome in Patients With NAFLD and FibrosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT01849081
Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty LiverNo drug interventionstreatmentNot Availablewithdrawn
NCT01629095
Genetic Studies of Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT04147195
Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)treatment2terminated
NCT02303314
Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver DiseaseNo drug interventionstreatment2 / 3completed
NCT01007955
Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT04365855
The Olmsted NAFLD Epidemiology Study (TONES)No drug interventionsdiagnosticNot Availablerecruiting
NCT06244550
Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic FactorstreatmentNot Availablecompleted
NCT06032650
Calisthenics Versus High Intensity Interval Training in NAFLNo drug interventionstreatmentNot Availablerecruiting
NCT04782050
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology ConsultationNo drug interventionsdiagnosticNot Availablecompleted
NCT04315350
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin ResistancepreventionNot Availableterminated
NCT02579408
Quantifying Steatosis in Liver Transplant DonorsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05907408
Omics Techniques in Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03060538
A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Diseasetreatment1completed
NCT02599038
Serine Supplementation for Obese Subjects With Fatty Liver DiseaseNo drug interventionsdiagnostic1 / 2completed
NCT04573543
The Role of Immune Semaphorins in NAFLDNo drug interventionsNot AvailableNot Availablecompleted
NCT04938843
Effect of F. Prausnitzii on Glycemic ControlNo drug interventionstreatmentNot Availableunknown_status
NCT03936803
Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04004403
Alternate Day Fasting, Exercise, and NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT05189990
Electrical Impedance Tomography in Fatty Liver DetectionNo drug interventionsNot AvailableNot Availablecompleted
NCT03848390
Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).No drug interventionstreatmentNot Availableunknown_status
NCT00262964
Obesity and Nonalcoholic Fatty Liver DiseasetreatmentNot Availablecompleted
NCT02075164
Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLDNo drug interventionspreventionNot Availableunknown_status
NCT05231564
Hybrid Training and Middle AgeNo drug interventionssupportive_careNot Availablecompleted
NCT03061721
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitistreatment2completed
NCT01431521
Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)treatment1completed
NCT00677521
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)treatment2terminated
NCT03866421
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney TransplantationNo drug interventionsNot AvailableNot Availableterminated
NCT05067621
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Diseasetreatment2recruiting
NCT06138821
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06167902
The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04899102
Intermittent Fasting for NAFLD in AdultsNo drug interventionstreatmentNot Availablerecruiting
NCT02860884
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04523584
Ultrasound Quantification of Liver FatNo drug interventionsNot AvailableNot Availablecompleted
NCT05256979
Ursodeoxycholic Acid in Patients With NAFLD - Clinical ObservationNo drug interventionsNot AvailableNot Availablerecruiting
NCT06176079
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver DiseaseNot AvailableNot Availablerecruiting
NCT01548079
Ursodeoxycholic Acid in Bariatric Surgerybasic_scienceNot Availablecompleted
NCT05979779
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic SteatohepatitisNo drug interventionstreatment2active_not_recruiting
NCT04197479
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patientstreatment3completed
NCT03492879
Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases SeverityNo drug interventionsdiagnosticNot Availableunknown_status
NCT03867487
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Diseasetreatment2not_yet_recruiting
NCT05305287
Quantifying Hepatic Mitochondrial Fluxes in Humansbasic_science4recruiting
NCT01056133
Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)No drug interventionstreatment2completed
NCT02420054
Short Term Intermittent Fasting and Insulin ResistanceNo drug interventionstreatmentNot Availableunknown_status
NCT04435054
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.No drug interventionsscreeningNot Availableunknown_status
NCT05447351
Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese SubjectsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04038853
Vitamin D in Fatty Liver Diseasetreatment4completed
NCT05194553
Identification and Characterization of NAFLD in TurkeyNo drug interventionsNot AvailableNot Availablecompleted
NCT05676177
CT Liver Fat Fraction QuantificationNo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT00889577
Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected PersonsNo drug interventionsNot AvailableNot Availablecompleted
NCT02124577
Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLDNo drug interventionsNot AvailableNot Availableunknown_status
NCT06552377
Ultrasound and Attenuation ImagingNo drug interventionsNot AvailableNot Availablecompleted
NCT02764047
Probiotics in the Treatment of NAFLDNo drug interventionstreatmentNot Availableunknown_status
NCT03526445
Hepatic Metabolic Changes in Response to Glucagon Infusionbasic_scienceNot Availablecompleted
NCT05042245
The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsulestreatment4unknown_status
NCT02329405
The Effects of PXR Activation on Hepatic Fat Contentbasic_science4completed
NCT05728697
Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05520697
Exercise and Cerebral Hemodynamics in MAFLD.No drug interventionstreatmentNot Availablerecruiting
NCT05046483
Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMINo drug interventionsNot AvailableNot Availablerecruiting
NCT03281083
Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)treatment2terminated
NCT04642261
Effect of Empagliflozin on Liver Fat in Non-diabetic Patientstreatment4completed
NCT03701828
Liver Health and Metabolic Function in People With ObesityNo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT01759628
Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatment2completed
NCT03426111
Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).No drug interventionstreatmentNot Availableunknown_status
NCT05292911
Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)treatment1completed
NCT02863393
Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablewithdrawn
NCT05528471
Fructose and Liver Diseases in Youth: Help Them FLYNo drug interventionstreatmentNot Availablerecruiting
NCT03068078
A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 DiabetesNo drug interventionstreatmentNot Availablecompleted
NCT05968378
Diet, Immunometabolism and Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT02663388
Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)No drug interventionsNot AvailableNot Availablerecruiting
NCT05073588
Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD ChildrenNo drug interventionstreatmentNot Availablecompleted
NCT03375788
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risktreatment2active_not_recruiting
NCT05792488
Lifestyle Guidance Methods in NAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT06354088
Human Models of Selective Insulin Resistance: Alpelisib, Part Ibasic_science1recruiting
NCT01167088
A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)treatment2terminated
NCT05754385
Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT04598685
Early Vascular Ageing in the YOUthNo drug interventionsNot AvailableNot Availablecompleted
NCT02884037
Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)Not AvailableNot Availablecompleted
NCT02526732
Hepatic Inflammation and Physical Performance in Patients With NASHNo drug interventionssupportive_careNot Availablecompleted
NCT04918732
NAFLD Primary CareNo drug interventionsdiagnosticNot Availablerecruiting
NCT02366052
Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot StudyNo drug interventionstreatment2completed
NCT05357352
Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT05292352
Prevention of NAFLD in Hispanic ChildrenNo drug interventionspreventionNot Availablerecruiting
NCT06520800
Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through ExerciseNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03186859
Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)No drug interventionstreatmentNot Availablecompleted
NCT05551559
The Effect of Bariatric Surgery on Hepatic Metabolism in Non-Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT05563259
Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT06266559
Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03884075
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)basic_science2recruiting
NCT06374875
Fibrosis Lessens After Metabolic SurgeryNo drug interventionstreatment4recruiting
NCT03535142
Prognostic Significance of Fatty Liver Disease in Bariatric PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT06218342
Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Diseasetreatment4not_yet_recruiting
NCT06061042
Effect of Timed-Restricted Eating on Metabolic HealthNo drug interventionstreatmentNot Availablerecruiting
NCT04857606
Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver DiseaseNo drug interventionsbasic_science1completed
NCT05766449
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT02242149
Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjectstreatment3completed
NCT05808049
A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver HealthNo drug interventionsotherNot Availablecompleted
NCT04190849
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)No drug interventionsNot AvailableNot Availablerecruiting
NCT03260036
Hepatic Urea Nitrogen Handling in Patients With NASHNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02369536
Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatmentNot Availablecompleted
NCT06225713
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)No drug interventionstreatmentNot Availablerecruiting
NCT00230113
Effect of Omega-3 PUFA Supplementation in NAFLD PatientsNo drug interventionsNot Available2completed
NCT05332613
Diet and Meal Timing in Patients With Non-Alcoholic Fatty Liver Disease: A Pilot StudyNo drug interventionspreventionNot Availablerecruiting
NCT00760513
Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acidstreatment4completed
NCT00586313
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)No drug interventionsdiagnosticNot Availablecompleted
NCT06104319
Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASHNo drug interventionstreatment2recruiting
NCT01988441
The Influence of Autophagy on Fatty LiverNo drug interventionsNot AvailableNot Availablerecruiting
NCT02488941
Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT04340817
Fatty Liver Disease in Nordic CountriesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02679417
The Effects of Type of Exercise in Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04555434
Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASHNo drug interventionsscreeningNot Availableunknown_status
NCT04520724
Functional Roll for Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT00641524
Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04640324
Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.treatmentNot Availablecompleted
NCT04237116
A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)treatment3terminated
NCT00794716
Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)diagnostic2completed
NCT01371396
Effect of Dietary Macronutrient CompositionNo drug interventionsbasic_scienceNot Availablecompleted
NCT05480696
Soluble Fibre Supplementation in NAFLDNo drug interventionstreatment1recruiting
NCT01306396
Effect of Fructose Reduction on Non-alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome in Overweight ChildrenNo drug interventionspreventionNot Availableunknown_status
NCT05216796
Healthy Liver - Healthy BrainNo drug interventionsbasic_scienceNot Availablerecruiting
NCT05463796
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04049396
Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatmentNot Availablecompleted
NCT01094158
Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitistreatment2completed
NCT03166735
Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASHNo drug interventionstreatment2completed
NCT03864835
NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction ReversalNo drug interventionstreatmentNot Availablewithdrawn
NCT05786963
Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and SteatosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05546086
BeijngFH Health Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06097039
Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03614039
Effect of Probiotic and Smectite Gel on NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT05804422
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)No drug interventionstreatmentNot Availablecompleted
NCT03942822
Chia Supplementation and Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04859322
The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnoverbasic_scienceNot Availablecompleted
NCT03875625
Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style InterventionNo drug interventionstreatmentNot Availablerecruiting
NCT02147925
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjectstreatment4completed
NCT02650830
Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative StressNo drug interventionsNot AvailableNot Availablecompleted
NCT02303730
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetestreatment4completed
NCT03842748
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02267148
Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver ProgressionNo drug interventionsNot AvailableNot Availablecompleted
NCT05357248
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASHNo drug interventionstreatmentNot Availablecompleted
NCT05987748
The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03681457
Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjectstreatment1completed
NCT03179657
Guangzhou Nutrition and Health Study (GNHS)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05618626
Prevention of NAFLD and CVD Through Lifestyle InterventionNo drug interventionspreventionNot Availablerecruiting
NCT03143166
Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japantreatment1completed
NCT05637866
SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic OutcomesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05419765
Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03350165
A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)treatment2completed
NCT02649465
SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLDtreatment4completed
NCT02728765
Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT03068065
Antidiabetic Effects on Intrahepatic Fattreatment4completed
NCT04579874
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.No drug interventionsdiagnosticNot Availablecompleted
NCT06571474
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)No drug interventionsNot AvailableNot Availablerecruiting
NCT03436420
Gemcabene for the Treatment of Pediatric NAFLDtreatment2terminated
NCT01472120
Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionsNot AvailableNot Availableunknown_status
NCT04540731
Multicenter Registry of Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04004273
Diabetes, Exercise and Liver Fat (DELIVER)No drug interventionstreatmentNot Availablecompleted
NCT03184376
Histological Improvement of NASH With PrebioticNo drug interventionstreatmentNot Availablecompleted
NCT00389376
Phase I Trial of Silymarin for Chronic Liver Diseasesbasic_science1completed
NCT01317576
Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver!No drug interventionstreatmentNot Availablecompleted
NCT04364360
Sulforaphane Supplementation StudyNo drug interventionsbasic_scienceNot Availableunknown_status
NCT05180760
Smartphone App for Non-alcoholic Fatty Liver DiseaseNo drug interventionssupportive_careNot Availablerecruiting
NCT04720560
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03060694
Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness MeasurementsNo drug interventionsNot AvailableNot Availablecompleted
NCT03663062
ObeSity Related Colorectal Adenoma RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT04411862
Efficacy of Phosphatidylcholine in NAFLDNo drug interventionstreatment3completed
NCT06519162
Liver-gut Axis Study Through Identification of Liver Disease-specific MicrobiomeNo drug interventionsNot AvailableNot Availablerecruiting
NCT01285362
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) StudytreatmentNot Availablecompleted
NCT03625362
Hydrogen-rich Water for Non-alchoholic Fatty Liver DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT03613480
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)No drug interventionstreatmentNot Availableunknown_status
NCT00714129
De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver DiseaseNo drug interventionsbasic_scienceNot Availablecompleted
NCT05654129
Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionsotherNot Availablerecruiting
NCT06256289
Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrometreatment4not_yet_recruiting
NCT02875392
Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionsotherNot Availablecompleted
NCT03864744
Hepatic Histology and Metabolism Following Total Pancreatectomy and PancreaticoduodenectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02784444
A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASHNo drug interventionstreatment2completed
NCT03803540
Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic SteatohepatitisNo drug interventionstreatment1unknown_status
NCT01680640
Investigation of Synbiotic Treatment in NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT06064240
Liver Fat Content and Bariatric SurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02174367
An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe PsoriasisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05203367
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy SubjectsNo drug interventionsother1withdrawn
NCT05611567
Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT05578404
High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Diseasetreatment2completed
NCT05291104
Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver ProgressionNo drug interventionstreatmentNot Availableunknown_status
NCT05807204
Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal ObesityNo drug interventionstreatmentNot Availablecompleted
NCT03250572
Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01747772
Sonoelastography: Ultrasound Method to Measure Liver FibrosisNo drug interventionsdiagnosticNot Availablecompleted
NCT04807868
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)No drug interventionsNot AvailableNot Availablerecruiting
NCT02391168
Fatty Liver Disease Collaborative Research in ChinaNo drug interventionsNot AvailableNot Availableunknown_status
NCT06450769
Aronia and Non-alcoholic Fatty Liver DiseaseNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03059446
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitistreatment2terminated
NCT04341246
Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)No drug interventionsNot AvailableNot Availablecompleted
NCT03938246
Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)treatment2completed
NCT02506946
NAFLD in Adolescents and Young Adults With PCOSNo drug interventionsNot AvailableNot Availableunknown_status
NCT05130346
Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionssupportive_careNot Availablewithdrawn
NCT04182646
Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT02779946
Non-invasive Liver Screening for Risk Assessment for Coronary Heart DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05054712
Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes MellitusNo drug interventionsNot AvailableNot Availableunknown_status
NCT02950610
Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT06355310
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Diseasetreatment2not_yet_recruiting
NCT05821010
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitistreatment2recruiting
NCT05941910
The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial FunctionNo drug interventionstreatment2recruiting
NCT03826381
NAFLD Among Patients With Type 2 Diabetes and CKDNo drug interventionsNot AvailableNot Availablecompleted
NCT03156881
Global Osteopathic Treatment for Patients With NAFLDNo drug interventionstreatmentNot Availableunknown_status
NCT05395481
A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Nonalcoholic Fatty Liver DiseaseNo drug interventionsbasic_science1recruiting
NCT02535195
Effect of Ginger Supplement on Non-alcoholic Fatty LiverNo drug interventionstreatment2 / 3completed
NCT02973295
Silymarin in NAFLDtreatment4withdrawn
NCT02681055
Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjectstreatment2completed
NCT04230655
Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric BalloonNo drug interventionstreatmentNot Availableunknown_status
NCT02985450
A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in CanadaNot AvailableNot Availablecompleted
NCT05623150
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic SyndromeNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06373523
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozintreatment0not_yet_recruiting
NCT04657523
Ultrasound-Based Liver Fat Quantification (LFQ) Pilot StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT05275608
Effects of VLCKD in Metabolic SyndromeNo drug interventionstreatmentNot Availablerecruiting
NCT02086708
Ultrasound Method to Measure Fibrosis of the Liver in ChildrenNo drug interventionsdiagnosticNot Availableterminated
NCT03787108
Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or ObesityNo drug interventionsNot AvailableNot Availableunknown_status
NCT05696808
Effect of Indian Hepatoprotective Diet in Reversibility of NAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT03190538
Nonalcoholic Steatohepatitis in Chinese ChildrenNo drug interventionsNot AvailableNot Availablerecruiting
NCT00819338
The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatment2completed
NCT05858138
To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver DiseaseNo drug interventionspreventionNot Availablerecruiting
NCT03073343
A Prospective, Randomized, Open Label Trial of Two Doses of Oral BetaineNo drug interventionstreatmentNot Availablerecruiting
NCT05035043
Economic Burden of NAFLDNo drug interventionsotherNot Availableactive_not_recruiting
NCT06623084
Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06627114
Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease PatientsNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT06477146
Milk Thistle Clinical Trial in Pediatric NAFLDtreatment2recruiting
NCT04165343
Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORERNo drug interventionsNot AvailableNot Availablecompleted
NCT02037321
Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic RiskNo drug interventionsNot AvailableNot Availableunknown_status
NCT01790984
How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?No drug interventionsbasic_scienceNot Availablecompleted
NCT00968747
Regulation of FGF21 by Nutritional ChallengesNo drug interventionsotherNot Availablecompleted
NCT04099147
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.No drug interventionsNot AvailableNot Availableunknown_status
NCT04019561
A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.treatment2completed
NCT03776175
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.treatment2completed
NCT04450875
Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT05908006
Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01997424
Association of Non-alcoholic Fatty Liver Disease and Diabetes MellitusNo drug interventionsdiagnosticNot Availablecompleted
NCT02605616
Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatment2terminated
NCT02457286
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Studytreatment1withdrawn
NCT06127225
Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatment2recruiting
NCT03151473
Longitudinal Observational Study Of Chinese With NAFLD/NASHNo drug interventionsNot AvailableNot Availablerecruiting
NCT01418027
Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatment3completed
NCT02491229
"Hepafast" in Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatmentNot Availablecompleted
NCT06218589
Non-Invasive Diagnostic Tests for MASLD in Pediatric PopulationNo drug interventionsdiagnosticNot Availablerecruiting
NCT00771108
Exercise Dose and Nonalcoholic Fatty Liver DiseaseNo drug interventionsbasic_scienceNot Availablecompleted
NCT01110577
Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)No drug interventionsNot AvailableNot Availablecompleted
NCT04282005
Metabolic Surgery for Steato-HepatitisNo drug interventionstreatmentNot Availableunknown_status
NCT01477307
Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty LiverNo drug interventionsNot AvailableNot Availablecompleted
NCT02754037
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05384652
Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis AssessmentNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04682600
The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFFNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT00375349
Non Alcoholic Fatty Liver Disease Influence of Statin TherapyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04820036
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)No drug interventionsotherNot Availableactive_not_recruiting
NCT05699018
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic PatientsNo drug interventionsscreeningNot Availablerecruiting
NCT04330326
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Diseasetreatment2unknown_status
NCT02654665
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adultstreatment3unknown_status
NCT05051527
Study to Evaluate the Effectiveness of Legalon®Not AvailableNot Availablerecruiting
NCT02194894
The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease PatientsotherNot Availablewithdrawn
NCT01811472
Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patientstreatment2completed
NCT04639414
Combined Active Treatment in Type 2 Diabetes With NASHtreatment4active_not_recruiting
NCT05648214
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Non-Alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatment1recruiting
NCT01894438
Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted